WHO/N. Thomas
© Credits

Vaccines and immunization

    Overview

    Immunization is a global health and development success story, saving millions of lives every year. Vaccines reduce risks of getting a disease by working with your body’s natural defences to build protection. When you get a vaccine, your immune system responds.

    We now have vaccines to prevent more than 20 life-threatening diseases, helping people of all ages live longer, healthier lives. Immunization currently prevents 3.5-5 million deaths every year from diseases like diphtheria, tetanus, pertussis, influenza and measles.

    Immunization is a key component of primary health care and an indisputable human right. It’s also one of the best health investments money can buy. Vaccines are also critical to the prevention and control of infectious disease outbreaks. They underpin global health security and will be a vital tool in the battle against antimicrobial resistance.

    Yet despite tremendous progress, vaccination coverage has plateaued in recent years and dropped since 2020. The COVID-19 pandemic and associated disruptions over the past two year have strained health systems, with 25 million children missing out on vaccination in 2021, 6 million more than in 2019 and the highest number since 2009.

    By the end of 2021, nearly all countries had introduced COVID-19 vaccination, and by early 2022 one billion doses of COVID-19 vaccine had been delivered through COVAX.


    Impact

    Vaccines train your immune system to create antibodies, just as it does when it’s exposed to a disease. However, because vaccines contain only killed or weakened forms of germs like viruses or bacteria, they do not cause the disease or put you at risk of its complications.

    Vaccines protect against many different diseases, including:

    • cervical cancer
    • cholera
    • COVID-19
    • diphtheria
    • hepatitis B
    • influenza
    • Japanese encephalitis
    • malaria
    • measles
    • meningitis
    • mumps
    • pertussis
    • pneumonia
    • polio
    • rabies
    • rotavirus
    • rubella
    • tetanus
    • typhoid
    • varicella
    • yellow fever

    Some other vaccines are currently being piloted, including those that protect against Ebola or malaria, but are not yet widely available globally.

    Not all these vaccinations may be needed in your country. Some may only be given prior to travel, in areas of risk, or to people in high-risk occupations. Talk to your healthcare worker to find out what vaccinations are needed for you and your family.
    WHO response

    WHO is working with countries and partners to improve global vaccination coverage, including through these initiatives adopted by the World Health Assembly in August 2020.

    Immunization Agenda 2030

    IA2030 sets an ambitious, overarching global vision and strategy for vaccines and immunization for the decade 2021–2030. It was co-created with thousands of contributions from countries and organizations around the world. It draws on lessons from the past decade and acknowledges continuing and new challenges posed by infectious diseases (e.g. Ebola, COVID-19).

    The strategy has been designed to respond to the interests of every country and intends to inspire and align the activities of community, national, regional and global stakeholders towards achieving a world where everyone, everywhere fully benefits from vaccines for good health and well-being. IA2030 is operationalized through regional and national strategies and a mechanism to ensure ownership and accountability and a monitoring and evaluation framework to guide country implementation.


     

    News

    All →

    Latest publications

    All →
    Good practice statement on the use of variant-containing COVID-19 vaccines

    This Good practice statement has been developed on the basis of advice issued by the Strategic Advisory Group of Experts (SAGE) on Immunization at its...

    WHO position paper on hepatitis A vaccines – October 2022

    This guidance document replaces the 2012 WHO position paper on hepatitis A vaccines.Since the publication of the first WHO hepatitis A vaccine position...

    Evaluation of COVID-19 vaccine effectiveness in a changing landscape of COVID-19 epidemiology and vaccination

    In March 2021 the World Health Organization (WHO) made interim guidance available on best practices for undertaking vaccine effectiveness (VE) evaluations...

    Interim recommendations for use of the Novavax NVX-CoV2373 vaccine against COVID-19

    These WHO interim recommendations for use of the Novavax NVX-CoV2373 vaccine were developed on the basis of advice issued by the Strategic Advisory Group...

    Documents

    All →

    The COVID-19 vaccine tracker and landscape compiles detailed information of each COVID-19 vaccine candidate in development by closely monitoring their...

    This resource explains how WHO EUL COVID-19 vaccines without vaccine vial monitor (VVM) should be handled at the vaccination site,...

    WHO Local Production and Assistance Unit (LPA) is organizing the Virtual cGMP Training Marathon for Vaccine Manufacturing in response to Member...

    WHO Local Production and Assistance Unit (LPA) is organizing the Virtual cGMP Training Marathon for Vaccine Manufacturing in response to Member...

    Our work

    Feature stories

    All →

    Infographics

    All →

    Videos

    All →

    Country profiles

    Country profiles present selected data, statistics and information to provide national health profiles at given points in time.
    GO

    Related health topic